ZURA
Zura Bio Limited Class A Ordinary SharesNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$413.68M
P/E Ratio
—
EPS
$-1.09
Beta
0.09
52W High
$7.44
52W Low
$0.98
50-Day MA
$5.38
200-Day MA
$4.46
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Zura Bio Limited Class A Ordinary Shares
Zura Bio Limited (Ticker: ZURA) is an innovative biotechnology firm dedicated to developing pioneering therapies for autoimmune disorders and rare diseases. With a promising pipeline of drug candidates, the company emphasizes rigorous clinical trials and state-of-the-art research techniques to drive its drug development efforts. Supported by an experienced management team and strategic collaborations, Zura Bio is well-positioned to capitalize on emerging opportunities within the biopharmaceutical landscape, making it an attractive prospect for institutional investors focused on advanced therapeutic solutions.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-81.44M |
| Operating Margin | 0.00% |
| Return on Equity | -41.00% |
| Return on Assets | -25.40% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $2.29 |
| Price-to-Book | 1.91 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | -2.34 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $94.88M |
| Float | $54.81M |
| % Insiders | 21.37% |
| % Institutions | 78.56% |
Historical Volatility
HV 10-Day
87.28%
HV 20-Day
75.68%
HV 30-Day
70.31%
HV 60-Day
69.54%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($15.67 target)
1
Strong Buy6
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026